These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8513470)

  • 1. [What is Hodgkin's disease?].
    Vernerová E; Tesarová P; Hermanská Z; Dienstbier Z
    Cas Lek Cesk; 1993 May; 132(9):257-60. PubMed ID: 8513470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of prognostic factors in Hodgkin's disease. Experience of the comprehensive rationale team in treating patients with Hodgkin's disease].
    Foltýnová V
    Cas Lek Cesk; 1986 May; 125(22):684-90. PubMed ID: 3708676
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical aspects and primary therapy of Hodgkin's lymphomas].
    Sieber M; Tesch H; Diehl V
    Praxis (Bern 1994); 1996 Mar; 85(12):364-70. PubMed ID: 8643899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The story about Hodgkin's lymphoma].
    Ostojić Kolonić S
    Acta Med Croatica; 2008 Oct; 62(4):409-12. PubMed ID: 19205418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summary of informal discussion on the prognostic and therapeutic implications of staging in Hodgkin's disease.
    Peters MV
    Cancer Res; 1971 Nov; 31(11):1851-3. PubMed ID: 5121691
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prognostic factors and treatment of advanced Hodgkin's disease].
    Fermé C
    Rev Prat; 1998 May; 48(10):1082-6. PubMed ID: 9781152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
    Wheeler C; Eickhoff C; Elias A; Ibrahim J; Ayash L; McCauley M; Mauch P; Schwartz G; Eder JP; Mazanet R; Ferrara J; Rimm IJ; Guinan E; Bierer B; Gilliland G; Churchill WH; Ault K; Parsons S; Antman K; Schnipper L; Tepler I; Gaynes L; Frei E; Kadin M; Antin J
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):98-106. PubMed ID: 9267670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
    Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
    Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic factors and treatment of localized Hodgkin's disease].
    Carde P; Cosset JM
    Rev Prat; 1998 May; 48(10):1075-81. PubMed ID: 9781151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant Hodgkin's and non-Hodgkin's lymphomas].
    Hiller E
    MMW Fortschr Med; 2005 Mar; 147(9):31-4. PubMed ID: 15794351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.
    Smith RS; Chen Q; Hudson MM; Link MP; Kun L; Weinstein H; Billett A; Marcus KJ; Tarbell NJ; Donaldson SS
    J Clin Oncol; 2003 May; 21(10):2026-33. PubMed ID: 12743158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.
    Brice P; Bouabdallah R; Moreau P; Divine M; André M; Aoudjane M; Fleury J; Anglaret B; Baruchel A; Sensebe L; Colombat P
    Bone Marrow Transplant; 1997 Jul; 20(1):21-6. PubMed ID: 9232251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary treatment of early stage Hodgkin's disease].
    Molnár Z; Esik O; Illés A
    Orv Hetil; 2005 Jan; 146(2):57-61. PubMed ID: 15724953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hodgkin's disease: biology can help the physician towards new prognostic factors and new therapeutic approaches].
    Rubio MT; Ghesquières H; Blay JY; Salles G
    Bull Cancer; 2001 Nov; 88(11):1081-90. PubMed ID: 11741802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary treatment of advanced Hodgkin's disease].
    Illés A; Udvardy M; Molnár Z
    Orv Hetil; 2005 Jan; 146(5):195-202. PubMed ID: 15773586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of resistant forms and recurrence of Hodgkin's disease].
    Diviné M; Reyes F
    Rev Prat; 1998 May; 48(10):1087-91. PubMed ID: 9781153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic models for Hodgkin's disease].
    Panyshin GA; Datsenko PV; Sotnikov VM; Mel'nik IuD
    Vopr Onkol; 2006; 52(5):538-43. PubMed ID: 17168362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in biology, diagnostics, and treatment of Hodgkin's disease.
    Küppers R; Yahalom J; Josting A
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):66-76. PubMed ID: 16399588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and therapeutic implications of staging in extranodal Hodgkin's disease.
    Musshoff K
    Cancer Res; 1971 Nov; 31(11):1814-27. PubMed ID: 5121688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.